72 related articles for article (PubMed ID: 12898150)
1. Human VAT-1: a calcium-regulated activation marker of human epithelial cells.
Koch J; Foekens J; Timmermans M; Fink W; Wirzbach A; Kramer MD; Schaefer BM
Arch Dermatol Res; 2003 Sep; 295(5):203-10. PubMed ID: 12898150
[TBL] [Abstract][Full Text] [Related]
2. Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact.
Schaefer BM; Koch J; Wirzbach A; Kramer MD
Exp Cell Res; 2001 Jun; 266(2):250-9. PubMed ID: 11399053
[TBL] [Abstract][Full Text] [Related]
3. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
Park GT; Seo EY; Lee KM; Lee DY; Yang JM
Br J Dermatol; 2006 Mar; 154(3):411-8. PubMed ID: 16445768
[TBL] [Abstract][Full Text] [Related]
4. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
6. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional characterization of the four-transmembrane molecule l6 in epidermal keratinocytes.
Storim J; Friedl P; Schaefer BM; Bechtel M; Wallich R; Kramer MD; Reinartz J
Exp Cell Res; 2001 Jul; 267(2):233-42. PubMed ID: 11426942
[TBL] [Abstract][Full Text] [Related]
8. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas.
Beckler A; Moskaluk CA; Zaika A; Hampton GM; Powell SM; Frierson HF; El-Rifai W
Cancer; 2003 Oct; 98(7):1547-51. PubMed ID: 14508844
[TBL] [Abstract][Full Text] [Related]
11. Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours.
Fuller PJ; Alexiadis M; Jobling T; McNeilage J
Clin Endocrinol (Oxf); 2005 Jul; 63(1):111-5. PubMed ID: 15963070
[TBL] [Abstract][Full Text] [Related]
12. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
16. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed.
Raymond AA; Méchin MC; Nachat R; Toulza E; Tazi-Ahnini R; Serre G; Simon M
Br J Dermatol; 2007 Mar; 156(3):420-7. PubMed ID: 17300228
[TBL] [Abstract][Full Text] [Related]
17. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
18. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
Baird J; Lazarus GS; Belin D; Vassalli JD; Busso N; Gubler P; Jensen PJ
J Invest Dermatol; 1990 Nov; 95(5):548-52. PubMed ID: 2121833
[TBL] [Abstract][Full Text] [Related]
19. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
20. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium.
Arredondo J; Chernyavsky AI; Jolkovsky DL; Webber RJ; Grando SA
J Cell Physiol; 2006 Jul; 208(1):238-45. PubMed ID: 16575903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
